Gedeon Richter: Cariprazine Proves Effective in Treating Dual Diagnosis
New analyses of cariprazine studies were presented by Gedeon Richter Plc. at 32e Annual Congress of the European Psychiatric Association held April 6-9 in Budapest, Hungary. According to scientific posters of the event, cariprazine could be an appropriate treatment not only for…
Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI® (olanzapine and samidorphan)
Alkermes plc (Nasdaq: ALKS) today announced topline results from a phase 3, open-label extension study assessing the long-term safety, tolerability and durability of treatment effect of LYBALVI® (olanzapine and samidorphan) in patients with schizophrenia, schizophreniform disorder or bipolar I disorder for up to…
Announcing 35th Annual Walk for Hope on Sunday, Oct 8
The Foundation of Hope for Research and Treatment of Mental Illness will hold its 35th Annual Thad and Alice Eure Walk for Hope on Sunday, October 8, 2023, from 9:00 am-2:00 pm at the Angus Barn restaurant in Raleigh, N.C….
